Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
State PolicyJune 29, 2026

NASHP Releases Model Legislation Tying State Drug Pricing to Medicare Negotiated Rates

The National Academy for State Health Policy published revised model legislation allowing states to reference Medicare Maximum Fair Prices negotiated under the Inflation Reduction Act when setting prescription drug payment rates for state programs. The model act would apply to state-funded programs including Medicaid fee-for-service and potentially managed care pharmacy benefits. States can adapt the model to tie reimbursement rates to Medicare's negotiated prices for high-cost drugs, creating potential benchmark pricing constraints. The legislation offers states a mechanism to leverage federal negotiating power for prescription drug cost containment.

Why it mattersMedicaid MCOs with pharmacy risk may face state-mandated maximum reimbursement rates linked to Medicare negotiated prices, affecting pharmacy benefit management strategies and capitation rate adequacy for high-cost drugs.

Pharmacy · Managed Care · Finance

Read the full article at nashp.org →
Also covered by:nashp.orgnashp.org
Share this briefing

You might also like

← All stories

Get the daily briefing.